• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CompuMed claims digital advance

Article

Bone densitometry firm CompuMed announced last week that it has successfully acquired images using both dual-energy x-ray absorptiometry and amorphous silicon x-ray detectors. The Manhattan Beach, CA, firm believes that being able to acquire such images

Bone densitometry firm CompuMed announced last week that it has successfully acquired images using both dual-energy x-ray absorptiometry and amorphous silicon x-ray detectors. The Manhattan Beach, CA, firm believes that being able to acquire such images will help the company in its development of Digital OsteoView 2000, a device designed to detect both osteoporosis and arthritis.

CompuMed scientists working with researchers at the University of Massachusetts used amorphous silicon flat-panel detectors licensed from Varian Associates, with whom CompuMed has an OEM agreement (SCAN 1/8/97). CompuMed plans to file for 510(k) clearance for Digital OsteoView 2000 later this year.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.